Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Depreciation and Depletion (2020 - 2025)

Historic Depreciation and Depletion for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to $17000.0.

  • Biofrontera's Depreciation and Depletion fell 1500.0% to $17000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $94000.0, marking a year-over-year increase of 1325.3%. This contributed to the annual value of $92000.0 for FY2024, which is 697.67% up from last year.
  • Biofrontera's Depreciation and Depletion amounted to $17000.0 in Q3 2025, which was down 1500.0% from $22000.0 recorded in Q2 2025.
  • Biofrontera's 5-year Depreciation and Depletion high stood at $33000.0 for Q1 2021, and its period low was $17000.0 during Q3 2025.
  • In the last 5 years, Biofrontera's Depreciation and Depletion had a median value of $22000.0 in 2021 and averaged $24105.3.
  • In the last 5 years, Biofrontera's Depreciation and Depletion plummeted by 2121.21% in 2022 and then skyrocketed by 4285.71% in 2024.
  • Biofrontera's Depreciation and Depletion (Quarter) stood at $22000.0 in 2021, then dropped by 4.55% to $21000.0 in 2022, then changed by 0.0% to $21000.0 in 2023, then skyrocketed by 42.86% to $30000.0 in 2024, then tumbled by 43.33% to $17000.0 in 2025.
  • Its Depreciation and Depletion stands at $17000.0 for Q3 2025, versus $22000.0 for Q2 2025 and $25000.0 for Q1 2025.